Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Completed · Phase 3

Conditions studied: Hodgkin Disease

In brief

Prophylactic use of Filgrastim SD/01 for patients with Hodgkin's lymphoma receiving ABVD chemotherapy.

Key facts

Study ID

NCT00038558

Run by

M.D. Anderson Cancer Center

People needed

25

Starts

2001-11-01

Expected to finish

2005-03-01

Last updated by the study team

2018-10-31

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.